Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings
- Status
- COMPLETED
- Phase
- NA
Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells
- Status
- COMPLETED
- Phase
- PHASE2
A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide After Allo Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Geriatric Assessments in Senior Adults With Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study)
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Dexamethasone With/Without Stem Cell Transplant in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)
- Status
- COMPLETED
- Phase
- PHASE2
Hemostatic Effects of VELCADE®* Treatment in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE1
A Dose-finding Study of the Bromodomain (Brd) Inhibitor OTX015/ Birabresib (MK-8628) in Hematologic Malignancies (MK-8628-001)
- Status
- COMPLETED
- Phase
- PHASE1